Developer docs
API playgroundTry for free, no card

Search company profiles

雅培(上海)诊断产品销售有限公司

Full company profile

uuid003uk7e

Namestring
雅培(上海)诊断产品销售有限公司
Legal namestring
雅培(上海)诊断产品销售有限公司
Websiteurl
alerechina.com
Company typeenum
Private
Founded yearstring
-
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersShanghai, China
HQ citystring
Shanghai
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
point-of-care diagnostics, rapid diagnostic testing, in-vitro diagnostic devices, clinical laboratory analyzers, medical diagnostic reagents
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • In Vitro & In Vivo Diagnostic Substances2835
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Point-of-Care Diagnostics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Rapid Point-of-Care Diagnostic Instruments
TypeHardware Sales
Description

Sale of diagnostic analyzers and test systems including Afinion 2, Determine, BinaxNOW, and i-STAT for use in healthcare settings at point of care.

globalpointofcare.abbott
2Diagnostic Test Reagents and Consumables
TypeOne Time License
Description

Recurring revenue from sale of test cartridges, reagents, and consumables for the diagnostic platforms. Testing reagents for HIV, influenza, cardiovascular markers, and other conditions.

globalpointofcare.abbott
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Afinion
Description

Rapid point-of-care testing system for HbA1c, ACR, CRP, and lipid panels

globalpointofcare.abbott
+2 more records
Core offering1 text field

The company sells and distributes Abbott's rapid point-of-care diagnostic instruments and consumables (Afinion 2 Analyzer, Determine HIV Early Detect, BinaxNOW Influenza A & B Card, Afinion CRP) to healthcare institutions in China. The portfolio enables bedside testing with results in minutes using fingertip blood or swab samples, eliminating the need to send samples to a central laboratory. It is the Chinese commercial entity for Abbott's Global Point of Care diagnostics division, supporting cardiovascular, infectious disease, and chronic disease testing at the point of care.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Results available within minutes during consultation rather than days for laboratory testing
+2 more records
Product overview1 text field

雅培(上海)诊断产品销售有限公司提供以 Afinion™ 2 系统为核心的快速床旁诊断产品组合。该组合包括 Afinion 2 分析仪(多项测定分析仪,提供 HbA1c、ACR、CRP 和血脂检测)、Afinion CRP(独立 CRP 检测模块)、Determine HIV Early Detect(HIV 早期检测)以及 BinaxNOW 甲乙型流感试剂卡。产品组合通过指尖采血或拭子样本实现即时诊断,无需将样本送至实验室,可在数分钟内提供检测结果,支持心血管疾病早筛、感染病诊断等应用场景。

Product and service1 record
1Afinion 2 Analyzer (Afinion 2 系统)
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Roche Diagnostics is the largest global IVD player and Abbott's main peer in rapid point-of-care diagnostics, with POC platforms (e.g., cobas Liat) spanning infectious disease, cardiac, and metabolic testing in hospitals and clinics in China.

TypeRegional player
Description

Mindray is one of China's largest medical device companies with growing POC and in-vitro diagnostic offerings that increasingly compete with Abbott's rapid diagnostic portfolio in Chinese hospitals.

TypeRegional player
Description

Wondfo is a leading Chinese POCT diagnostics company offering lower-priced rapid tests for infectious disease, fertility, and chronic conditions, directly competing with Abbott POC products in the Chinese market.

TypeRegional player
Description

Sinocare is a major Chinese diagnostic devices company with strong positions in blood glucose monitoring and other chronic disease POC tests, competing with Abbott's Afinion platform in Chinese clinics.

TypeDirect peer
Description

BD competes directly with Abbott in rapid POC infectious disease and chronic disease diagnostics via its BD Veritor System, addressing similar hospitals, clinics, and physician office customers in China.

TypeDirect peer
Description

Sysmex is a global IVD leader with a strong presence in hematology and POC diagnostics in Asia, competing with Abbott POC systems for clinical diagnostics business in Chinese hospitals and reference labs.

TypeDirect peer
Description

Cepheid's GeneXpert molecular POC system competes with Abbott's i-STAT and Determine rapid tests at the point of care, particularly for infectious disease testing in Chinese hospital and clinic settings.

TypeBroad incumbent
Description

Siemens Healthineers is a broad incumbent in diagnostics and medical devices with POC offerings (epoc, RAPIDPoint) that compete with Abbott's POC blood gas and chemistry analyzers in Chinese healthcare institutions.

TypeDirect peer
Description

bioMérieux is a leading microbiology and infectious disease diagnostics company whose VITEK, BioFire, and rapid test portfolios overlap with Abbott's infectious disease POC offerings distributed in China.

TypeDirect peer
Description

QuidelOrtho's Sofia and Triage rapid diagnostic platforms directly rival Abbott's BinaxNOW influenza and Afinion cardiac/metabolic assays in clinical POC settings, including the Chinese market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

雅培(上海)诊断产品销售有限公司

Point-of-Care Diagnosticsalerechina.com

雅培(上海)诊断产品销售有限公司 firmographics

Firmographics
Name
雅培(上海)诊断产品销售有限公司
Legal name
雅培(上海)诊断产品销售有限公司
Website
https://alerechina.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Where 雅培(上海)诊断产品销售有限公司 is headquartered

Location

Headquarters

HQ city
Shanghai
HQ country
China
HQ region
Asia

Offices1 record

Markets served

雅培(上海)诊断产品销售有限公司 business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D

Revenue model

  1. Rapid Point-of-Care Diagnostic Instruments: Sale of diagnostic analyzers and test systems including Afinion 2, Determine, BinaxNOW, and i-STAT for use in healthcare settings at point of care.
  2. Diagnostic Test Reagents and Consumables: Recurring revenue from sale of test cartridges, reagents, and consumables for the diagnostic platforms. Testing reagents for HIV, influenza, cardiovascular markers, and other conditions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

雅培(上海)诊断产品销售有限公司 product offering

Product offering

Core offering

The company sells and distributes Abbott's rapid point-of-care diagnostic instruments and consumables (Afinion 2 Analyzer, Determine HIV Early Detect, BinaxNOW Influenza A & B Card, Afinion CRP) to healthcare institutions in China. The portfolio enables bedside testing with results in minutes using fingertip blood or swab samples, eliminating the need to send samples to a central laboratory. It is the Chinese commercial entity for Abbott's Global Point of Care diagnostics division, supporting cardiovascular, infectious disease, and chronic disease testing at the point of care.

Product overview

雅培(上海)诊断产品销售有限公司提供以 Afinion™ 2 系统为核心的快速床旁诊断产品组合。该组合包括 Afinion 2 分析仪(多项测定分析仪,提供 HbA1c、ACR、CRP 和血脂检测)、Afinion CRP(独立 CRP 检测模块)、Determine HIV Early Detect(HIV 早期检测)以及 BinaxNOW 甲乙型流感试剂卡。产品组合通过指尖采血或拭子样本实现即时诊断,无需将样本送至实验室,可在数分钟内提供检测结果,支持心血管疾病早筛、感染病诊断等应用场景。

Differentiator

Problem solved

Functional benefit

Brands

  • Afinion: Rapid point-of-care testing system for HbA1c, ACR, CRP, and lipid panels
  • Determine
  • BinaxNOW

Products and services

  • Afinion 2 Analyzer (Afinion 2 系统)

Quantifiable outcome

  • Results available within minutes during consultation rather than days for laboratory testing
  • +2 more outcomes

Companies that use 雅培(上海)诊断产品销售有限公司

Customer profile

Segments3 records

Ideal customer profiles1 record

雅培(上海)诊断产品销售有限公司 technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

雅培(上海)诊断产品销售有限公司 partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

雅培(上海)诊断产品销售有限公司 competitors and assessment

Company assessment

Direct peers

  • Roche Diagnostics: Roche Diagnostics is the largest global IVD player and Abbott's main peer in rapid point-of-care diagnostics, with POC platforms (e.g., cobas Liat) spanning infectious disease, cardiac, and metabolic testing in hospitals and clinics in China.
  • BD (Becton, Dickinson and Company): BD competes directly with Abbott in rapid POC infectious disease and chronic disease diagnostics via its BD Veritor System, addressing similar hospitals, clinics, and physician office customers in China.
  • Sysmex Corporation: Sysmex is a global IVD leader with a strong presence in hematology and POC diagnostics in Asia, competing with Abbott POC systems for clinical diagnostics business in Chinese hospitals and reference labs.
  • Cepheid (Danaher): Cepheid's GeneXpert molecular POC system competes with Abbott's i-STAT and Determine rapid tests at the point of care, particularly for infectious disease testing in Chinese hospital and clinic settings.
  • bioMérieux: bioMérieux is a leading microbiology and infectious disease diagnostics company whose VITEK, BioFire, and rapid test portfolios overlap with Abbott's infectious disease POC offerings distributed in China.
  • QuidelOrtho: QuidelOrtho's Sofia and Triage rapid diagnostic platforms directly rival Abbott's BinaxNOW influenza and Afinion cardiac/metabolic assays in clinical POC settings, including the Chinese market.

Regional players

  • Mindray Bio-Medical Electronics: Mindray is one of China's largest medical device companies with growing POC and in-vitro diagnostic offerings that increasingly compete with Abbott's rapid diagnostic portfolio in Chinese hospitals.
  • Wondfo Biotech: Wondfo is a leading Chinese POCT diagnostics company offering lower-priced rapid tests for infectious disease, fertility, and chronic conditions, directly competing with Abbott POC products in the Chinese market.
  • Sinocare Inc. Sinocare is a major Chinese diagnostic devices company with strong positions in blood glucose monitoring and other chronic disease POC tests, competing with Abbott's Afinion platform in Chinese clinics.

Broad incumbents

  • Siemens Healthineers: Siemens Healthineers is a broad incumbent in diagnostics and medical devices with POC offerings (epoc, RAPIDPoint) that compete with Abbott's POC blood gas and chemistry analyzers in Chinese healthcare institutions.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

雅培(上海)诊断产品销售有限公司 social profiles

Digital presence

雅培(上海)诊断产品销售有限公司 compliance and trust

Trust signal

Compliance1 record

雅培(上海)诊断产品销售有限公司 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

雅培(上海)诊断产品销售有限公司 leadership team

Management profile

Number of profiles

Profiles1 record

雅培(上海)诊断产品销售有限公司 funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

雅培(上海)诊断产品销售有限公司 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 雅培(上海)诊断产品销售有限公司

What does 雅培(上海)诊断产品销售有限公司 do?

The company sells and distributes Abbott's rapid point-of-care diagnostic instruments and consumables (Afinion 2 Analyzer, Determine HIV Early Detect, BinaxNOW Influenza A & B Card, Afinion CRP) to healthcare institutions in China. The portfolio enables bedside testing with results in minutes using fingertip blood or swab samples, eliminating the need to send samples to a central laboratory. It is the Chinese commercial entity for Abbott's Global Point of Care diagnostics division, supporting cardiovascular, infectious disease, and chronic disease testing at the point of care.

Is 雅培(上海)诊断产品销售有限公司 a public or private company?

雅培(上海)诊断产品销售有限公司 is a private company. It is classified as corporate owned and is currently operating.

When was 雅培(上海)诊断产品销售有限公司 founded?

雅培(上海)诊断产品销售有限公司 was founded in -1. It employs 1 to 10 people.

Where is 雅培(上海)诊断产品销售有限公司 based?

雅培(上海)诊断产品销售有限公司 is headquartered in Shanghai, China, in the Asia region.

How does 雅培(上海)诊断产品销售有限公司 make money?

Two revenue lines are on record. Rapid Point-of-Care Diagnostic Instruments are the primary driver. The others are diagnostic Test Reagents and Consumables.

Who are 雅培(上海)诊断产品销售有限公司's main competitors?

Direct peers on record are Roche Diagnostics, BD (Becton, Dickinson and Company), Sysmex Corporation, Cepheid (Danaher), bioMérieux and QuidelOrtho. Regional players are Mindray Bio-Medical Electronics, Wondfo Biotech and Sinocare Inc.. Siemens Healthineers is listed as a broad incumbent.

Does 雅培(上海)诊断产品销售有限公司 have an API?

No public API is recorded for 雅培(上海)诊断产品销售有限公司.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales